Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Hayden

Showing results (21-30 of 432) with videos related to

Pageof 44
Sort By:
Trends in Cardiovascular Medicine|July 27, 2010
Adenosine-triphosphate-binding cassette transporter-1 trafficking and functionMartin H Kang, Roshni Singaraja, Michael R Hayden
Molecular Neurobiology|November 16, 2014
Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington DiseaseJolene Ooi, Michael R Hayden, Mahmoud A Pouladi
Journal of Medical Genetics|September 21, 2011
Lessons from predictive testing for Huntington disease: 25 years onAlice K Hawkins, Anita Ho, Michael R Hayden
International Journal of Molecular Sciences|April 30, 2021
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative DiseasesVladimir Zhemkov, Michal Geva, Michael R Hayden, et al.
Diabetes|August 22, 2015
Comment on Rickels et al. Loss-of-Function Mutations in ABCA1 and Enhanced β-Cell Secretory Capacity in Young Adults. Diabetes 2015;64:193-199Jay V Patankar, Liam R Brunham, Michael R Hayden
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2009
CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approachesDouglas R Langbehn, Michael R Hayden, Jane S Paulsen, et al.
Trends in Genetics : TIG|June 30, 2006
To be or not to be toxic: aggregations in Huntington and Alzheimer diseaseElizabeth J Slow, Rona K Graham, Michael R Hayden
Nature Reviews. Drug Discovery|September 22, 2018
Therapeutic approaches to Huntington disease: from the bench to the clinicNicholas S Caron, E Ray Dorsey, Michael R Hayden
Trends in Neurosciences|October 25, 2011
Caspase-6 and neurodegenerationRona K Graham, Dagmar E Ehrnhoefer, Michael R Hayden
Nature Reviews. Neuroscience|September 21, 2013
Choosing an animal model for the study of Huntington's diseaseMahmoud A Pouladi, A Jennifer Morton, Michael R Hayden
Pageof 44

Showing results (21-30 of 432) with videos related to

Sort By:
Pageof 44
Trends in Cardiovascular Medicine|July 27, 2010
Adenosine-triphosphate-binding cassette transporter-1 trafficking and functionMartin H Kang, Roshni Singaraja, Michael R Hayden
Molecular Neurobiology|November 16, 2014
Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington DiseaseJolene Ooi, Michael R Hayden, Mahmoud A Pouladi
Journal of Medical Genetics|September 21, 2011
Lessons from predictive testing for Huntington disease: 25 years onAlice K Hawkins, Anita Ho, Michael R Hayden
International Journal of Molecular Sciences|April 30, 2021
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative DiseasesVladimir Zhemkov, Michal Geva, Michael R Hayden, et al.
Diabetes|August 22, 2015
Comment on Rickels et al. Loss-of-Function Mutations in ABCA1 and Enhanced β-Cell Secretory Capacity in Young Adults. Diabetes 2015;64:193-199Jay V Patankar, Liam R Brunham, Michael R Hayden
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2009
CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approachesDouglas R Langbehn, Michael R Hayden, Jane S Paulsen, et al.
Trends in Genetics : TIG|June 30, 2006
To be or not to be toxic: aggregations in Huntington and Alzheimer diseaseElizabeth J Slow, Rona K Graham, Michael R Hayden
Nature Reviews. Drug Discovery|September 22, 2018
Therapeutic approaches to Huntington disease: from the bench to the clinicNicholas S Caron, E Ray Dorsey, Michael R Hayden
Trends in Neurosciences|October 25, 2011
Caspase-6 and neurodegenerationRona K Graham, Dagmar E Ehrnhoefer, Michael R Hayden
Nature Reviews. Neuroscience|September 21, 2013
Choosing an animal model for the study of Huntington's diseaseMahmoud A Pouladi, A Jennifer Morton, Michael R Hayden
Pageof 44